These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 6683955

  • 1. Effects of a continuous estrogen-progestogen therapy for climacteric symptoms on circulating sex steroids and gonadotrophins.
    Mattsson LA, Abrahamsson L, Cullberg G, Samsioe G.
    Arch Gynecol; 1983; 233(2):101-7. PubMed ID: 6683955
    [Abstract] [Full Text] [Related]

  • 2. Estrogen-progestogen replacement in climacteric women, particularly as regards a new type of continuous regimen.
    Mattsson LA, Samsioe G.
    Acta Obstet Gynecol Scand Suppl; 1985; 130():53-8. PubMed ID: 3859976
    [Abstract] [Full Text] [Related]

  • 3. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density.
    Rannevik G, Jeppsson S, Johnell O, Bjerre B, Laurell-Borulf Y, Svanberg L.
    Maturitas; 1995 Feb; 21(2):103-13. PubMed ID: 7752947
    [Abstract] [Full Text] [Related]

  • 4. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
    Moutos D, Smith S, Zacur H.
    Contraception; 1995 Aug; 52(2):105-9. PubMed ID: 8536446
    [Abstract] [Full Text] [Related]

  • 5. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate.
    Furuhjelm M, Carlström K.
    Acta Obstet Gynecol Scand; 1977 Aug; 56(4):351-61. PubMed ID: 602703
    [Abstract] [Full Text] [Related]

  • 6. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
    Dören M, Rübig A, Coelingh Bennink HJ, Holzgreve W.
    Fertil Steril; 2001 Mar; 75(3):554-9. PubMed ID: 11239541
    [Abstract] [Full Text] [Related]

  • 7. Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women.
    Dören M, Reuther G, Minne HW, Schneider HP.
    Am J Obstet Gynecol; 1995 Nov; 173(5):1446-51. PubMed ID: 7503183
    [Abstract] [Full Text] [Related]

  • 8. Time-related effects of a progestogen on the isoforms of serum gonadotrophins in 17 beta-oestradiol treated post-menopausal women.
    Wide L, Naessén T, Eriksson K, Rune C.
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):651-8. PubMed ID: 8759177
    [Abstract] [Full Text] [Related]

  • 9. Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone binding globulin.
    Kraemer GR, Kraemer RR, Ogden BW, Kilpatrick RE, Gimpel TL, Castracane VD.
    Fertil Steril; 2003 Mar; 79(3):534-42. PubMed ID: 12620436
    [Abstract] [Full Text] [Related]

  • 10. Endocrine, neuroendocrine and behavioral effects of oral dehydroepiandrosterone sulfate supplementation in postmenopausal women.
    Stomati M, Rubino S, Spinetti A, Parrini D, Luisi S, Casarosa E, Petraglia F, Genazzani AR.
    Gynecol Endocrinol; 1999 Feb; 13(1):15-25. PubMed ID: 10368794
    [Abstract] [Full Text] [Related]

  • 11. Plasma concentrations of unconjugated and conjugated estrogens and gonadotrophins following application of various estrogen preparations after oophorectomy and in the menopause.
    Strecker JR, Lauritzen C, Goessens L.
    Maturitas; 1979 Feb; 1(3):183-90. PubMed ID: 228157
    [Abstract] [Full Text] [Related]

  • 12. Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause.
    Jensen J, Christiansen C, Rødbro P.
    N Engl J Med; 1985 Oct 17; 313(16):973-5. PubMed ID: 4047104
    [Abstract] [Full Text] [Related]

  • 13. Endocrinological features and endometrial morphology in climacteric women receiving hormone replacement therapy.
    Grasso A, Baraghini F, Barbieri C, Dalla Vecchia E, Previdi AM, Di Renzo GC, Volpe A.
    Maturitas; 1982 Apr 17; 4(1):19-26. PubMed ID: 6285153
    [Abstract] [Full Text] [Related]

  • 14. A continuous estrogen-progestogen regimen for climacteric complaints. Effects on lipid and lipoprotein metabolism.
    Mattsson LA, Cullberg G, Samsioe G.
    Acta Obstet Gynecol Scand; 1984 Apr 17; 63(8):673-7. PubMed ID: 6524301
    [Abstract] [Full Text] [Related]

  • 15. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M, Monteleone P, Casarosa E, Quirici B, Puccetti S, Bernardi F, Genazzani AD, Rovati L, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2000 Oct 17; 14(5):342-63. PubMed ID: 11109974
    [Abstract] [Full Text] [Related]

  • 16. A prospective long-term study in women from pre-menopause to post-menopause: changing profiles of gonadotrophins, oestrogens and androgens.
    Rannevik G, Carlström K, Jeppsson S, Bjerre B, Svanberg L.
    Maturitas; 1986 Dec 17; 8(4):297-307. PubMed ID: 2952867
    [Abstract] [Full Text] [Related]

  • 17. The effect of 2 mg estradiol-17 beta plus 1 mg estriol, sequentially combined with 1 mg norethisteroneacetate, on LH, FSH, estradiol-17 beta, progesterone, testosterone and prolactin after ovariectomy.
    Kemeter P, Bernaschek G, Altmann G, Feichtinger W.
    Arch Gynecol; 1984 Dec 17; 234(3):219-29. PubMed ID: 6428330
    [Abstract] [Full Text] [Related]

  • 18. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH, Lahti EI, Kauppila AJ, Apaja-Sarkkinen MA, Laatikainen TJ.
    Am J Obstet Gynecol; 1995 Jan 17; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [Abstract] [Full Text] [Related]

  • 19. Percutaneous estrogen replacement therapy. Effects on circulating estrogens, gonadotropins and prolactin.
    Holst J, Cajander S, Carlström K, Damber MG, von Schoultz B.
    Acta Obstet Gynecol Scand; 1983 Jan 17; 62(1):49-53. PubMed ID: 6858624
    [Abstract] [Full Text] [Related]

  • 20. The effect of estrogen treatment on plasma concentrations of steroid hormones, gonadotropins, prolactin and sex hormone-binding globulin in post-menopausal women.
    Mathur RS, Landgrebe SC, Moody LO, Semmens JP, Williamson HO.
    Maturitas; 1985 Jul 17; 7(2):129-33. PubMed ID: 3929023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.